CMS-203

N/A

Report date: 2023/12/26 20:04:01
NME

Base Information

Drug NameCMS-203
Drug Alias NameCMS-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Lukang Pharmaceutical Co LtdShanghai Zhongtuo Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJinan Meiluwei Biotechnology Co LtdShandong Lukang Pharmaceutical Co LtdShanghai Zhongtuo Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A